Literature DB >> 23645940

Estimating Optimal Treatment Regimes from a Classification Perspective.

Baqun Zhang1, Anastasios A Tsiatis, Marie Davidian, Min Zhang, Eric Laber.   

Abstract

A treatment regime maps observed patient characteristics to a recommended treatment. Recent technological advances have increased the quality, accessibility, and volume of patient-level data; consequently, there is a growing need for powerful and flexible estimators of an optimal treatment regime that can be used with either observational or randomized clinical trial data. We propose a novel and general framework that transforms the problem of estimating an optimal treatment regime into a classification problem wherein the optimal classifier corresponds to the optimal treatment regime. We show that commonly employed parametric and semi-parametric regression estimators, as well as recently proposed robust estimators of an optimal treatment regime can be represented as special cases within our framework. Furthermore, our approach allows any classification procedure that can accommodate case weights to be used without modification to estimate an optimal treatment regime. This introduces a wealth of new and powerful learning algorithms for use in estimating treatment regimes. We illustrate our approach using data from a breast cancer clinical trial.

Entities:  

Keywords:  classification; doubly robust estimator; inverse probability weighting; personalized medicine; potential outcomes; propensity score

Year:  2012        PMID: 23645940      PMCID: PMC3640350          DOI: 10.1002/sta.411

Source DB:  PubMed          Journal:  Stat        ISSN: 0038-9986


  12 in total

1.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Demystifying optimal dynamic treatment regimes.

Authors:  Erica E M Moodie; Thomas S Richardson; David A Stephens
Journal:  Biometrics       Date:  2007-06       Impact factor: 2.571

3.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

4.  Regret-regression for optimal dynamic treatment regimes.

Authors:  Robin Henderson; Phil Ansell; Deyadeen Alshibani
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

5.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

6.  Variable Selection for Qualitative Interactions.

Authors:  L Gunter; J Zhu; S A Murphy
Journal:  Stat Methodol       Date:  2011-01-30

7.  A robust method for estimating optimal treatment regimes.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrics       Date:  2012-05-02       Impact factor: 2.571

8.  Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

Authors:  B Fisher; C Redmond; A Brown; D L Wickerham; N Wolmark; J Allegra; G Escher; M Lippman; E Savlov; J Wittliff
Journal:  J Clin Oncol       Date:  1983-04       Impact factor: 44.544

9.  Testing for qualitative interactions between treatment effects and patient subsets.

Authors:  M Gail; R Simon
Journal:  Biometrics       Date:  1985-06       Impact factor: 2.571

10.  Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

View more
  71 in total

1.  Random forests of interaction trees for estimating individualized treatment effects in randomized trials.

Authors:  Xiaogang Su; Annette T Peña; Lei Liu; Richard A Levine
Journal:  Stat Med       Date:  2018-04-29       Impact factor: 2.373

2.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

3.  Identifying optimal biomarker combinations for treatment selection via a robust kernel method.

Authors:  Ying Huang; Youyi Fong
Journal:  Biometrics       Date:  2014-08-14       Impact factor: 2.571

4.  Efficient augmentation and relaxation learning for individualized treatment rules using observational data.

Authors:  Ying-Qi Zhao; Eric B Laber; Yang Ning; Sumona Saha; Bruce E Sands
Journal:  J Mach Learn Res       Date:  2019       Impact factor: 3.654

5.  Identification of the optimal treatment regimen in the presence of missing covariates.

Authors:  Ying Huang; Xiao-Hua Zhou
Journal:  Stat Med       Date:  2019-11-27       Impact factor: 2.373

6.  ON ESTIMATION OF THE OPTIMAL TREATMENT REGIME WITH THE ADDITIVE HAZARDS MODEL.

Authors:  Suhyun Kang; Wenbin Lu; Jiajia Zhang
Journal:  Stat Sin       Date:  2018-07       Impact factor: 1.261

7.  Generated effect modifiers (GEM's) in randomized clinical trials.

Authors:  Eva Petkova; Thaddeus Tarpey; Zhe Su; R Todd Ogden
Journal:  Biostatistics       Date:  2016-07-27       Impact factor: 5.899

8.  Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective.

Authors:  Xiaofei Bai; Anastasios A Tsiatis; Wenbin Lu; Rui Song
Journal:  Lifetime Data Anal       Date:  2016-08-01       Impact factor: 1.588

9.  TARGETED SEQUENTIAL DESIGN FOR TARGETED LEARNING INFERENCE OF THE OPTIMAL TREATMENT RULE AND ITS MEAN REWARD.

Authors:  Antoine Chambaz; Wenjing Zheng; Mark J van der Laan
Journal:  Ann Stat       Date:  2017-12-15       Impact factor: 4.028

10.  Evaluating marker-guided treatment selection strategies.

Authors:  Roland A Matsouaka; Junlong Li; Tianxi Cai
Journal:  Biometrics       Date:  2014-04-29       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.